COVID-19 and HIV infection co-pandemics and their impact: a review of the literature

Coronavirus disease 2019 (COVID-19) was first detected in December 2019. In March 2020, the World Health Organization declared COVID-19 a pandemic. People with underlying medical conditions may be at greater risk of infection and experience complications from COVID-19. COVID-19 has the potential to...

Full description

Saved in:
Bibliographic Details
Published in:AIDS research and therapy 2021-05, Vol.18 (1), p.28-28, Article 28
Main Authors: Gatechompol, Sivaporn, Avihingsanon, Anchalee, Putcharoen, Opass, Ruxrungtham, Kiat, Kuritzkes, Daniel R
Format: Article
Language:English
Subjects:
AIDS/HIV
Analysis
Antiretroviral agents
Care and treatment
Clinical
Co-infection
Comorbidity
Complications
Coronaviruses
COVID-19
Development and progression
Diagnosis
Evaluation
Health risks
Health services
HIV
HIV infection
Human immunodeficiency virus
Immune response
Immunosuppressive agents
Infections
Literature reviews
Mortality
Outcome
Pandemics
Pathophysiology
Public health
Review
Severe acute respiratory syndrome coronavirus 2
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Coronavirus disease 2019 (COVID-19) was first detected in December 2019. In March 2020, the World Health Organization declared COVID-19 a pandemic. People with underlying medical conditions may be at greater risk of infection and experience complications from COVID-19. COVID-19 has the potential to affect People living with HIV (PLWH) in various ways, including be increased risk of COVID-19 acquisition and interruptions of HIV treatment and care. The purpose of this review article is to evaluate the impact of COVID-19 among PLWH. The contents focus on 4 topics: (1) the pathophysiology and host immune response of people infected with both SARS-CoV-2 and HIV, (2) present the clinical manifestations and treatment outcomes of persons with co-infection, (3) assess the impact of antiretroviral HIV drugs among PLWH infected with COVID-19 and (4) evaluate the impact of the COVID-19 pandemic on HIV services.
ISSN:1742-6405
1742-6405
DOI:10.1186/s12981-021-00335-1